{"Title": ["Cumberland Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?", "Ocular (OCUL) Submits an sNDA for Eye Pain Drug Dextenza", "Flexion Starts Phase III Enrollment on Zilretta for Hip OA", "Small Drug Stocks Near-Term Outlook Positive, Despite Headwinds", "Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss, Misses Revenue Estimates", "Cumberland Pharmaceuticals, Inc. (CPIX) and Recro Pharma Inc (REPH) Lead 9 Notable Investor Filings", "Health Care Sector Update for 11/24/2015: CPIX,AEZS,AEZ.TO,ADRO", "Pernix Co-Promotes with Cumberland - Analyst Blog", "Cumberland Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?", "Sector Update: Healthcare", "CPIX Reports Encouraging Data - Analyst Blog", "Zacks #1 Rank Additions for Friday - Tale of the Tape", "Company News for February 10, 2012 - Corporate Summary", "Sector Update: Healthcare Shares Mixed On Results; Cumberland Down 14%, WellCare Hits 52 Week Highs, Navidea Down 4%"], "Elapsed Time": ["JAN 25, 2019", "JAN 11, 2019", "JAN 3, 2019", "DEC 19, 2018", "NOV 13, 2018", "MAY 22, 2017", "NOV 24, 2015", "OCT 29, 2013", "JAN 25, 2019", "AUG 7, 2013", "SEP 20, 2012", "AUG 24, 2012", "FEB 10, 2012", "AUG 7, 2013"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/cumberland-pharmaceuticals-sees-hammer-chart-pattern%3A-time-to-buy-2019-01-25", "https://www.nasdaq.com/articles/ocular-ocul-submits-an-snda-for-eye-pain-drug-dextenza-2019-01-11", "https://www.nasdaq.com/articles/flexion-starts-phase-iii-enrollment-on-zilretta-for-hip-oa-2019-01-03", "https://www.nasdaq.com/articles/small-drug-stocks-near-term-outlook-positive-despite-headwinds-2018-12-19", "https://www.nasdaq.com/articles/cumberland-pharmaceuticals-cpix-reports-q3-loss-misses-revenue-estimates-2018-11-13", "https://www.nasdaq.com/articles/cumberland-pharmaceuticals-inc.-cpix-and-recro-pharma-inc-reph-lead-9-notable-investor", "https://www.nasdaq.com/articles/health-care-sector-update-11242015-cpixaezsaeztoadro-2015-11-24", "https://www.nasdaq.com/articles/pernix-co-promotes-with-cumberland-analyst-blog-2013-10-29", "https://www.nasdaq.com/articles/cumberland-pharmaceuticals-sees-hammer-chart-pattern%3A-time-to-buy-2019-01-25", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-08-07-0", "https://www.nasdaq.com/articles/cpix-reports-encouraging-data-analyst-blog-2012-09-20", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-friday-tale-of-the-tape-2012-08-24", "https://www.nasdaq.com/articles/company-news-for-february-10-2012-corporate-summary-2012-02-10", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-mixed-results-cumberland-down-14-wellcare-hits-52-week"], "Content": []}